Yingjie Peng

Title: Innovations of Yingjie Peng in Functional Polypeptides

Introduction

Yingjie Peng is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of functional polypeptides. His innovative work has led to the creation of methods that enhance the functionality of various proteins.

Latest Patents

Yingjie Peng holds a patent for "Methods and compositions related to functional polypeptides embedded in heterologous protein scaffolds." This invention provides methods for generating functional derivatives of effector polypeptides, such as hormones and receptor ligands, embedded in different protein scaffolds, like antibody scaffolds. The methods involve modifying the effector polypeptide with a combinatorial library of terminal linker sequences, inserting the modified sequences into the host scaffold, and selecting functional derivatives from the library of modified polypeptide sequences embedded in the host scaffold. The invention also includes specific functional derivatives of leptin, scFSH, and scRelaxin embedded in an antibody scaffold, along with therapeutic applications of these functional fusion molecules. Yingjie Peng has 1 patent to his name.

Career Highlights

Throughout his career, Yingjie Peng has worked with notable organizations, including The Scripps Research Institute and Zebra Biologics, Inc. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Yingjie has collaborated with esteemed colleagues such as Richard A. Lerner and Ronald M. Lindsay. These collaborations have further enriched his research and innovation in the field.

Conclusion

Yingjie Peng's contributions to the field of biotechnology through his innovative methods for functional polypeptides have the potential to impact therapeutic applications significantly. His work exemplifies the importance of innovation in advancing scientific knowledge and improving health outcomes.